NVAX


Stock Update (NASDAQ:NVAX): Novavax, Inc. Appoints Gail Boudreaux to Board

Novavax, Inc. (NASDAQ:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced the appointment …

Insider Selling News: Avalanche Biotechnologies Inc (AAVL), Novavax, Inc. (NVAX), Yelp Inc (YELP), salesforce.com, inc. (CRM)

Recently, various executives have taken part in insider selling activity for the stocks of Avalanche Biotechnologies Inc (NASDAQ:AAVL), Novavax, Inc. (NASDAQ:NVAX), Yelp Inc …

Insider Selling News: Gilead Sciences, Inc. (GILD), Twitter Inc (TWTR), Intercept Pharmaceuticals Inc (ICPT), Novavax, Inc. (NVAX)

Recently, various executives have taken part in insider selling activity for the stocks of Gilead Sciences, Inc. (NASDAQ:GILD), Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Twitter Inc (NYSE:TWTR), …

MLV Defends Novavax, Inc. Following Fast Track Designation for AstraZeneca’s MEDI8897

MLV analyst Vernon Bernardino came out today with a favorable report on Novavax, Inc. (NASDAQ:NVAX), as Fast Track designation was given by the FDA to MEDI-8897, a …

J.P. Morgan Reiterates Upbeat View Of Novavax Following 4Q Results

In a research report issued today, J.P.

MLV Reiterates Buy On Novax As Company Releases New Data From RSV F Protein Nanoparticle Vaccine

In a research note released today, MLV analyst George Zavoico reiterated a Buy rating on Novax (NASDAQ:NVAX) with a $14 price target, following …

We Envision Novavax Building A Strong RSV Franchise With Broad Applicability, Says MLV

In a research note issued this morning, MLV analyst George Zavoico reiterated a Buy rating on Novavax (NASDAQ:NVAX) with a $14 price target, …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts